Leriglitazone
N/A
Report date: 2024/06/20 18:02:29
NME
Base Information
Drug NameLeriglitazone
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[13]
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesPfizer IncTakeda Pharmaceutical Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesMinoryx Therapeutics SlSperogenix Therapeutics Ltd
Inactive CompaniesN/A
Active Indications
Inactive Indications